Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection
- 1 October 1988
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 56 (10) , 2563-2569
- https://doi.org/10.1128/iai.56.10.2563-2569.1988
Abstract
During a sublethal murine infection with Listeria monocytogenes cells, tumor necrosis factor (TNF) activity was detectable in neither sera nor spleen homogenates at any stage of the infection when a bioassay with L-929 cells (less than 4 U/ml) was used. However, injecting the mice with an immunoglobulin fraction obtained from a rabbit hyperimmunized with recombinant murine TNF-alpha resulted in acceleration of listeriosis. When 1 mg of anti-TNF antibody was injected per mouse, all the mice died from listeriosis, even though the infectious dose was sublethal for the untreated controls. The antigen-specific elimination of the bacterium from the spleens and livers of anti-TNF antibody-treated mice was delayed, depending on the dose of the antibody injected. Endogenous TNF seemed to be produced early in infection, because suppression of antilisterial resistance was significant when a single injection of anti-TNF antibody was given between day zero and day 2 of infection. The effect of endogenous TNF on antilisterial resistance was due to neither regulation of alpha interferon (IFN-alpha) and IFN-gamma production nor induction of IFN-beta subtype 1 (IFN-beta 1), because anti-TNF antibody treated-mice produced normal levels of IFN-alpha and IFN-gamma in the bloodstream during infection and administration of monoclonal anti-murine IFN-beta 1 antibody had no effect on the development of listeriosis. Alternatively, the listericidal activity of peritoneal macrophages of L. monocytogenes-infected mice could be abrogated by injection of anti-TNF antibody in vivo. These results suggest that the lower level of TNF is produced endogenously in mice that received L. monocytogenes infection and that it plays an essential role in the host defense against L. monocytogenes infection.This publication has 40 references indexed in Scilit:
- Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.The Journal of Experimental Medicine, 1987
- Interferon beta 1, an intermediate in the tumor necrosis factor alpha-induced increased MHC class I expression and an autocrine regulator of the constitutive MHC class I expression.The Journal of Experimental Medicine, 1987
- Interferon γ and lymphotoxin or tumor necrosis factor act synergistically to induce macrophage killing of tumor cells and schistosomula of schistosoma mansoniThe Journal of Experimental Medicine, 1987
- Secretory products of macrophages.Journal of Clinical Investigation, 1987
- Induction of β2-interferon by tumor necrosis factor: A homeostatic mechanism in the control of cell proliferationCell, 1986
- Alternative induction of alpha/beta interferons and gamma interferon by Listeria monocytogenes in mouse spleen cell culturesCellular Immunology, 1983
- Interferon-γ production byListeria monocytogenes-specific T cells active in cellular antibacterial immunityEuropean Journal of Immunology, 1983
- Enhanced production of murine interferon gamma by T cells generated in response to bacterial infection.The Journal of Experimental Medicine, 1982
- Specific Lyt 123 cells are involved in protection against Listeria monocytogenes and in delayed-type hypersensitivity to listerial antigens.The Journal of Experimental Medicine, 1979
- REQUIREMENT OF THYMUS (T) LYMPHOCYTES FOR RESISTANCE TO LISTERIOSISThe Journal of Experimental Medicine, 1972